We regret to report that long term Pfizer Inc. (NYSE:PFE) shareholders have had that experience, with the share price ...

Pfizer's stock is down roughly 60% from its late 2021 highs, but the drug giant is working to innovate its way back into the ...

Pfizer Inc. (NYSE:PFE) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 16, Pfizer Inc. (NYSE ...

A great dividend stock is one that's supported by a financially healthy, stable, and mature company with a proven commitment ...

Pfizer shares fall after a muted 2026 outlook, with projected modest revenue growth, lower COVID sales and deal dilution weighing on investor sentiment.

How $2,670 split across three durable high-yield stocks can generate $300 in annual dividends without risky payouts.

Pfizer Inc. (NYSE:PFE) is one of the best affordable healthcare stocks to buy now. Scotiabank analyst Louise Chen reiterated ...

In a notable shift in investment strategy, Meyer Handelman Co. has reduced its stake in Pfizer Inc. (NYSE: PFE) by 3.3%, selling 42,830 shares during the third quarter. This move leaves the ...

Pfizer's Eliquis, a blood thinner and one of its best-selling therapies, will lose patent exclusivity within the next few years. In the meantime, the company's performance leaves a lot to be desired.

Goldman Sachs reported a 1.21 percent return for the Tactical Tilt Overlay Fund in a strong third quarter. Review these ...

In a surprising turn of events, Pfizer has adjusted its profit forecast for 2026, indicating a potential decline in earnings that falls short of Wall Street expectations. This announcement has raised ...

Pfizer's profits will fall short of Wall Street estimates next year, as it faces weaker sales of COVID products and squeezed ...